Zhengyun Liu
Overview
Explore the profile of Zhengyun Liu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
53
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wu S, Wang H, Yang Q, Liu Z, Du J, Wang L, et al.
Cancer Lett
. 2024 Jun;
597:217058.
PMID: 38880226
Objective: N6-methyladenosine (M6A) is the most prevalent epigenetic alteration. Methyltransferase-like 3 (METTL3) is a key player in the control of M6A modification. Methyltransferase promote the processing of mature miRNA in...
2.
High-pressure Hydrodynamic Injection as a Method of Establishing Hepatitis B Virus Infection in Mice
Wen J, Chen G, Wang T, Yu W, Liu Z, Wang H
Comp Med
. 2024 Feb;
74(1):19-24.
PMID: 38365263
Among several existing mouse models for hepatitis B virus (HBV) infection, the high-pressure hydrodynamic injection (HDI) method is frequently used in HBV research due to its economic advantages and ease...
3.
Zhang W, Yang H, Liu Z, Wang S, Chen T, Song H, et al.
Virus Res
. 2023 Nov;
339:199267.
PMID: 37949375
EV71, a significant pathogen causing hand-foot-mouth disease, is associated with severe neurological complications such as brain stem encephalitis, aseptic meningitis, and acute flaccid paralysis. While the role of mitochondrial dynamics...
4.
Wang L, Shao A, Huang F, Liu Z, Wang Y, Huang X, et al.
Exp Dermatol
. 2023 Apr;
32(6):831-839.
PMID: 37017196
Basal cell carcinoma (BCC) and squamous cell carcinoma (SCC) are the two most common skin cancer and impose a huge medical burden on society. Histopathological examination based on whole-slide images...
5.
Wang L, Jiang Z, Shao A, Liu Z, Gu R, Ge R, et al.
Front Med (Lausanne)
. 2022 Oct;
9:976467.
PMID: 36237543
Purpose: The lack of finely annotated pathologic data has limited the application of deep learning systems (DLS) to the automated interpretation of pathologic slides. Therefore, this study develops a robust...
6.
Liu Z, Xu Y, Zhang W, Gao X, Luo G, Song H, et al.
Sci Rep
. 2021 May;
11(1):10381.
PMID: 34001947
JS-K, a nitric oxide-releasing diazeniumdiolates, is effective against various tumors. We have discovered that JS-K was effective against Hepatitis B virus (HBV)-positive HepG2.2.15 cells. This study used iTRAQ to identify...
7.
Liu Z, Xu K, Xu Y, Zhang W, Jiang N, Wang S, et al.
PeerJ
. 2020 Nov;
8:e9754.
PMID: 33150055
Realgar (AsS) has been used in traditional Chinese medicines for treatment of malignancies. The poor solubility of AsS hampered its clinical applications. Realgar quantum dots (RQDs) were developed to overcome...
8.
Liu Z, Li G, Gou Y, Xiao D, Luo G, Saavedra J, et al.
Biomed Pharmacother
. 2017 Jun;
92:989-997.
PMID: 28605880
Hepatocellular carcinoma (HCC) is the most important cause of cancer-related death, and 85% of HCC is caused by chronic HBV infection, the prognosis of patients and the reduction of HBV...
9.
Dong R, Wang X, Wang H, Liu Z, Liu J, Saavedra J
Biomed Pharmacother
. 2017 Jan;
88:367-373.
PMID: 28122301
JS-K is a novel anticancer nitric oxide (NO) prodrug effective against a variety of cancer cells, including the inhibition of AM-1 hepatoma cell growth in rats. To further evaluate anticancer...
10.
Wang H, Liu Z, Gou Y, Qin Y, Xu Y, Liu J, et al.
Int J Nanomedicine
. 2015 Sep;
10:5505-12.
PMID: 26357474
Realgar (AS4S4) has been used in traditional medicines for malignancy, but the poor water solubility is still a major hindrance to its clinical use. Realgar quantum dots (RQDs) were therefore...